{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T05:01:46Z","timestamp":1789794106281,"version":"4.0.1"},"reference-count":54,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Auburn University","id":[{"id":"https:\/\/ror.org\/02v80fc35","id-type":"ROR","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/02v80fc35","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacy"],"abstract":"<jats:p>The opioid epidemic continues to be a major public health crisis in the United States, and nalmefene has recently emerged as an alternative opioid overdose reversal agent. However, little is known about pharmacists\u2019 awareness and beliefs regarding nalmefene use and distribution. Therefore, the purpose of this study was to assess Alabama pharmacists\u2019 knowledge, perceptions, and behavioral intentions related to nalmefene. This study used a cross-sectional survey design. Practicing pharmacists in the state of Alabama were eligible to participate, and were recruited through the Alabama Board of Pharmacy email listserv. An anonymous online survey was distributed via email, and respondents were eligible to enter a lottery for one of five $100 electronic gift cards. The survey instrument was developed by the investigators, adapted from prior overdose reversal literature and informed by the Theory of Planned Behavior. Primary outcome measures included: knowledge of nalmefene (12 items); perceived barriers regarding nalmefene stocking and recommendations (19 items); and Theory of Planned Behavior concepts including attitudes (15 items), subjective norms (perceived social support) (six items), perceived behavioral control (confidence in ability to stock or recommend nalmefene) (11 items), and behavioral intentions surrounding nalmefene stocking and recommendations (13 items). Outcomes were measured via multiple-choice (objective knowledge) and Likert-type scale (1 = strongly disagree, 5 = strongly agree) questions. Differences in mean scale scores across pharmacy setting (pharmacists employed in inpatient versus outpatient settings), community pharmacy type (chain vs. independent), and geographic location (rural vs. urban) were analyzed using two-sided Mann\u2013Whitney U tests for non-parametric data or t-tests for parametric data, as appropriate. Multiple linear regression analyses examined associations between TPB constructs and pharmacists\u2019 intentions to stock or recommend nalmefene over the next six months. All data were analyzed using SPSS statistical software version 29 with an alpha of 0.05. There were 119 pharmacist respondents (n = 25 inpatient, n = 94 outpatient). The majority were female (68.1%), White (94.1%), and worked in community settings (35.3% independent, 10.9% corporate, 10.1% big-box, 5.0% grocery). Median age was 42 years (IQR: 36\u201351). Awareness of nalmefene was low: only 39.5% had heard of it and 5.9% had seen it in practice. Inpatient versus outpatient pharmacists reported higher subjective norms external to the workplace (median [IQR]: 3.00 [2.33, 3.58] vs. 2.33 [1.67, 3.00]; p = 0.004) as well as subjective knowledge (mean [SD]: 2.96 [0.94] vs. 2.55 [0.74]; p = 0.023), while outpatient versus inpatient pharmacists reported higher perceived barriers related to fiscal\/logistical concerns (mean [SD]: 3.45 [0.59] vs. 3.07 [0.66]; p = 0.009). Among community pharmacists, stocking and procurement confidence was higher among independent versus chain pharmacists (3.75 [3.00\u20134.17] vs. 3.17 [2.67\u20133.92]; p = 0.026). Furthermore, external workplace norms among urban pharmacists were higher than among rural pharmacists (2.50 [2.00\u20133.00] vs. 2.33 [1.67, 2.67]; p = 0.027), while stocking and procurement confidence was higher among rural than urban pharmacists (3.83 [2.83\u20134.50] vs. 3.17 [2.67\u20134.00]; p = 0.034). In adjusted reduced regression models, perceived behavioral control regarding nalmefene stocking and procurement (B = 0.189, 95% CI: 0.049, 0.329; p = 0.009), subjective norms external to the workplace (B = 0.232, 95% CI: 0.047, 0.418; p = 0.015), and interprofessional recommendation attitudes (B = 0.237, 95% CI: 0.037, 0.437; p = 0.021) positively predicted nalmefene implementation intentions. These findings suggest practice-setting differences that could be further explored for optimal implementation of nalmefene distribution and access, and highlight the need for targeted education, interprofessional collaboration, procurement guidance, and workflow tools to improve pharmacist preparedness for nalmefene services.<\/jats:p>","DOI":"10.3390\/pharmacy14060137","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:41:35Z","timestamp":1789645295000},"page":"137","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Knowledge and Beliefs Surrounding Nalmefene Among Alabama Pharmacists: A Cross-Sectional Survey Informed by the Theory of Planned Behavior"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7166-2587","authenticated-orcid":false,"given":"Nicholas P.","family":"McCormick","sequence":"first","affiliation":[{"name":"Harrison College of Pharmacy, Auburn University, 2316 Walker Building, Auburn, AL 36849, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"given":"Christian S.","family":"Flores","sequence":"additional","affiliation":[{"name":"Harrison College of Pharmacy, Auburn University, 2316 Walker Building, Auburn, AL 36849, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"validation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3359-2209","authenticated-orcid":false,"given":"Olivia","family":"Aycock","sequence":"additional","affiliation":[{"name":"Harrison College of Pharmacy, Auburn University, 2316 Walker Building, Auburn, AL 36849, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"validation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"given":"Victoria","family":"Patterson","sequence":"additional","affiliation":[{"name":"Harrison College of Pharmacy, Auburn University, 2316 Walker Building, Auburn, AL 36849, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"validation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"given":"Francesca","family":"Mengel","sequence":"additional","affiliation":[{"name":"Harrison College of Pharmacy, Auburn University, 2316 Walker Building, Auburn, AL 36849, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"validation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"given":"Shannon","family":"Woods","sequence":"additional","affiliation":[{"name":"Harrison College of Pharmacy, Auburn University, 2316 Walker Building, Auburn, AL 36849, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"given":"Erin","family":"Blythe","sequence":"additional","affiliation":[{"name":"Harrison College of Pharmacy, Auburn University, 2316 Walker Building, Auburn, AL 36849, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"given":"Olivia","family":"Radzinski","sequence":"additional","affiliation":[{"name":"Harrison College of Pharmacy, Auburn University, 2316 Walker Building, Auburn, AL 36849, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"given":"Madison","family":"Holland","sequence":"additional","affiliation":[{"name":"Harrison College of Pharmacy, Auburn University, 2316 Walker Building, Auburn, AL 36849, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"given":"Melissa","family":"Sanders","sequence":"additional","affiliation":[{"name":"Harrison College of Pharmacy, Auburn University, 2316 Walker Building, Auburn, AL 36849, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"given":"Kathlyn","family":"Smith","sequence":"additional","affiliation":[{"name":"Harrison College of Pharmacy, Auburn University, 2316 Walker Building, Auburn, AL 36849, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"given":"Autumn","family":"Randles","sequence":"additional","affiliation":[{"name":"Harrison College of Pharmacy, Auburn University, 2316 Walker Building, Auburn, AL 36849, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"given":"Emma","family":"Tidmore","sequence":"additional","affiliation":[{"name":"Harrison College of Pharmacy, Auburn University, 2316 Walker Building, Auburn, AL 36849, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"given":"Bryson","family":"Grimsley","sequence":"additional","affiliation":[{"name":"Harrison College of Pharmacy, Auburn University, 2316 Walker Building, Auburn, AL 36849, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7449-5358","authenticated-orcid":false,"given":"Anne","family":"Taylor","sequence":"additional","affiliation":[{"name":"Harrison College of Pharmacy, Auburn University, 2316 Walker Building, Auburn, AL 36849, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6505-7433","authenticated-orcid":false,"given":"Brandy","family":"Davis","sequence":"additional","affiliation":[{"name":"Harrison College of Pharmacy, Auburn University, 2316 Walker Building, Auburn, AL 36849, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8348-0895","authenticated-orcid":false,"given":"Lindsey","family":"Hohmann","sequence":"additional","affiliation":[{"name":"Harrison College of Pharmacy, Auburn University, 2316 Walker Building, Auburn, AL 36849, USA"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"ref_1","unstructured":"National Institute on Drug Abuse (2026, July 01). Drug Overdose Deaths: Facts and Figures, Available online: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/."},{"key":"ref_2","unstructured":"Centers for Disease Control and Prevention (2026, July 01). CDC Reports Nearly 24% Decline in U.S. Drug Overdose Deaths, Available online: https:\/\/www.cdc.gov\/media\/releases\/2025\/2025-cdc-reports-decline-in-us-drug-overdose-deaths.html."},{"key":"ref_3","unstructured":"The Global Statistics (2026, July 01). Opioid Crisis Statistics in the U.S 2025 | Facts About Opioid Crisis. Available online: https:\/\/www.theglobalstatistics.com\/united-states-opioid-crisis-statistics\/."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Spencer, M., Garnett, M., and Mini\u00f1o, A. (2022). Urban\u2013rural differences in drug overdose death rates, 2020. NCHS Data Briefs.","DOI":"10.15620\/118601"},{"key":"ref_5","unstructured":"Alabama Rural Health Association (2026, July 02). Definition of Rural Alabama. Available online: https:\/\/arhaonline.org\/definition-of-rural-alabama\/."},{"key":"ref_6","unstructured":"Kaiser Family Foundation (2026, July 02). Opioid Overdose Death Rates and All Drug Overdose Death Rates per 100,000 Population. Available online: https:\/\/www.kff.org\/mental-health\/state-indicator\/opioid-overdose-death-rates\/."},{"key":"ref_7","unstructured":"(2026, July 02). Alabama Drug Use Central Data Repository. Opioid Related Deaths, Available online: https:\/\/druguse.alabama.gov\/opioidrelateddeaths.html."},{"key":"ref_8","unstructured":"Centers for Disease Control and Prevention (2026, July 09). Opioid Dispensing Rate Maps | Overdose Prevention, Available online: https:\/\/www.cdc.gov\/overdose-prevention\/data-research\/facts-stats\/opioid-dispensing-rate-maps.html."},{"key":"ref_9","unstructured":"Alabama Operations Center Gulf Coast HIDTA (2026, July 17). ALABAMA 2025 DRUG THREAT ASSESSMENT, Available online: https:\/\/www.alabamapublichealth.gov\/pharmacy\/assets\/drugthreatassessment_2025.pdf."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/add.13326","article-title":"Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria","volume":"111","author":"McDonald","year":"2016","journal-title":"Addiction"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e200117","DOI":"10.1001\/jamanetworkopen.2020.0117","article-title":"Association of Take-Home Naloxone and Opioid Overdose Reversals Performed by Patients in an Opioid Treatment Program","volume":"3","author":"Katzman","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/cpdd.1312","article-title":"Pharmacokinetic Properties of an FDA-approved Intranasal Nalmefene Formulation for the Treatment of Opioid Overdose","volume":"13","author":"Crystal","year":"2024","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"ref_13","unstructured":"Food and Drug Administration (FDA) (2026, July 01). Highlights of Prescribing Information: Opvee (Nalmefene) Nasal Spray, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/217470Orig1s000.pdf."},{"key":"ref_14","unstructured":"Knoa Pharma (2026, July 08). Nalmefene HCl Injection. Available online: https:\/\/nalmefenehcl.com\/?gclsrc=aw.ds&gad_source=1&gad_campaignid=18862214331&gclid=CjwKCAjw6rfSBhAqEiwA_yocphKWx524Z1fS3JJdubQS2PxdHgNxRs-uPX2iH3ea37kRdJmx6EHpJhoCaLAQAvD_BwE."},{"key":"ref_15","unstructured":"Hospira Inc. (2026, July 01). NALOXONE HYDROCHLORIDE. Available online: https:\/\/labeling.pfizer.com\/showlabeling.aspx?id=4542."},{"key":"ref_16","unstructured":"MedScape (2026, July 08). Nalmefene (Zurnai) Dosing, Indications, Interactions, Adverse Effects, and More. Available online: https:\/\/reference.medscape.com\/drug\/zurnai-nalmefene-4000223."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s40262-024-01355-6","article-title":"Clinical Pharmacokinetics and Pharmacodynamics of Naloxone","volume":"63","author":"Saari","year":"2024","journal-title":"Clin. Pharmacokinet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0196-0644(05)80200-8","article-title":"Effectiveness and safety of intravenous nalmefene for emergency department patients with suspected narcotic overdose: A pilot study","volume":"22","author":"Kaplan","year":"1993","journal-title":"Ann. Emerg. Med."},{"key":"ref_19","unstructured":"Food and Drug Administration (FDA) (2026, July 06). FDA Approves First Nalmefene Hydrochloride Auto-Injector to Reverse Opioid Overdose, Available online: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-nalmefene-hydrochloride-auto-injector-reverse-opioid-overdose."},{"key":"ref_20","unstructured":"Matix Healthcare Services Inc. (2026, July 08). FDA Approves Nalmefene Auto-Injector to Reverse Opioid Overdose. Available online: https:\/\/www.mymatrixx.com\/news\/fda-approves-nalmefene-auto-injector-reverse-opioid-overdose."},{"key":"ref_21","unstructured":"Centers for Disease Control and Prevention (2026, July 09). Naloxone Dispensing Rate Maps | Overdose Prevention, Available online: https:\/\/www.cdc.gov\/overdose-prevention\/data-research\/facts-stats\/naloxone-dispensing-rate-maps.html."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"100326","DOI":"10.1016\/j.dadr.2025.100326","article-title":"Naloxone training programs in corporately-owned versus independently-owned Alabama community pharmacies: A pilot cross-sectional survey","volume":"15","author":"Blythe","year":"2025","journal-title":"Drug Alcohol Depend. Rep."},{"key":"ref_23","first-page":"100503","article-title":"A cross-sectional survey exploring organizational readiness to implement community pharmacy-based opioid counseling and naloxone services in rural versus urban settings in Alabama","volume":"16","author":"Hohmann","year":"2024","journal-title":"Explor. Res. Clin. Soc. Pharm."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1177\/10600280221120405","article-title":"Impact of a Multicomponent Educational Intervention on Community Pharmacy\u2013Based Naloxone Services Implementation: A Pragmatic Randomized Controlled Trial","volume":"57","author":"Hohmann","year":"2023","journal-title":"Ann. Pharmacother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.drugpo.2019.09.021","article-title":"Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama","volume":"74","author":"Sisson","year":"2019","journal-title":"Int. J. Drug Policy"},{"key":"ref_26","unstructured":"Heinrich Heine Universitat (2025, December 03). G*Power Manual. Available online: https:\/\/www.psychologie.hhu.de\/fileadmin\/redaktion\/Fakultaeten\/Mathematisch-Naturwissenschaftliche_Fakultaet\/Psychologie\/AAP\/gpower\/GPowerManual.pdf."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3352\/jeehp.2021.18.17","article-title":"Sample size determination and power analysis using the G*Power software","volume":"18","author":"Kang","year":"2021","journal-title":"J. Educ. Eval. Health Prof."},{"key":"ref_28","unstructured":"(2026, March 17). G*Power. Available online: https:\/\/www.psychologie.hhu.de\/arbeitsgruppen\/allgemeine-psychologie-und-arbeitspsychologie\/gpower."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0749-5978(91)90020-T","article-title":"Theories of Cognitive Self-Regulation, the Theory of Planned Behavior","volume":"50","author":"Ajzen","year":"1991","journal-title":"Organ. Behav. Hum. Decis. Process."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/0897190018759225","article-title":"Dispensing Naloxone Without a Prescription: Survey Evaluation of Ohio Pharmacists","volume":"32","author":"Thompson","year":"2019","journal-title":"J. Pharm. Pract."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/cpt.3514","article-title":"FDA Approval Summary: Nalmefene Nasal Spray for the Emergency Treatment of Known or Suspected Opioid Overdose","volume":"117","author":"Nallani","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_32","unstructured":"Food and Drug Administration (FDA) (2026, March 17). Office of Clinical Pharmacology Review: Opvee (Nalmefene HCl Nasal Spray), Available online: https:\/\/www.fda.gov\/media\/171605\/download."},{"key":"ref_33","unstructured":"Indivior (2026, March 17). How to Get OPVEE\u00ae\u2014OPVEE\u00ae Nasal Spray. Available online: https:\/\/opvee.com\/how-to-get-opvee\/."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.japh.2018.04.025","article-title":"Identifying barriers to dispensing naloxone: A survey of community pharmacists in North Carolina","volume":"58","author":"Rudolph","year":"2018","journal-title":"J. Am. Pharm. Assoc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF02289162","article-title":"Some necessary conditions for common-factor analysis","volume":"19","author":"Guttman","year":"1954","journal-title":"Psychometrika"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/001316446002000116","article-title":"The Application of Electronic Computers to Factor Analysis","volume":"20","author":"Kaiser","year":"1960","journal-title":"Educ. Psychol. Meas."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1037\/0033-2909.99.3.432","article-title":"Comparison of five rules for determining the number of components to retain","volume":"99","author":"Zwick","year":"1986","journal-title":"Psychol. Bull."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jbusres.2007.05.008","article-title":"Efficient theory development and factor retention criteria: Abandon the \u2018eigenvalue greater than one\u2019 criterion","volume":"61","author":"Patil","year":"2008","journal-title":"J. Bus. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1037\/1082-989X.4.3.272","article-title":"Evaluating the use of exploratory factor analysis in psychological research","volume":"4","author":"Fabrigar","year":"1999","journal-title":"Psychol. Methods"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/00273170902794206","article-title":"Exploratory Factor Analysis With Small Sample Sizes","volume":"44","author":"Dodou","year":"2009","journal-title":"Multivar. Behav. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5116\/ijme.4dfb.8dfd","article-title":"Making sense of Cronbach\u2019s alpha","volume":"2","author":"Tavakol","year":"2011","journal-title":"Int. J. Med. Educ."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ptsp.2018.05.002","article-title":"The use of parametric effect sizes in single study musculoskeletal physiotherapy research: A practical primer","volume":"32","author":"Pautz","year":"2018","journal-title":"Phys. Ther. Sport"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"102462","DOI":"10.1016\/j.cptl.2025.102462","article-title":"Core reporting expectations for quantitative manuscripts using independent and dependent t-tests, One-Way ANOVA, OLS regression, and Chi-Square","volume":"17","author":"Schreiber","year":"2025","journal-title":"Curr. Pharm. Teach. Learn."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ptsp.2018.07.009","article-title":"The use of nonparametric effect sizes in single study musculoskeletal physiotherapy research: A practical primer","volume":"33","author":"Pautz","year":"2018","journal-title":"Phys. Ther. Sport"},{"key":"ref_45","unstructured":"Alabama Rural Health Association (2026, July 02). Analysis of Urban vs. Rural. Available online: https:\/\/arhaonline.org\/analysis-of-urban-vs-rural\/."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1111\/add.13517","article-title":"Community pharmacist knowledge, attitudes and confidence regarding naloxone for overdose reversal","volume":"111","author":"Nielsen","year":"2016","journal-title":"Addiction"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Courtney, J., Kreys, E., Luu, B., Kreys, T., Vinall, R., Quang, V., and Titus-Lay, E. (2022). Effectiveness of an Advanced Naloxone Training, Simulation, and Assessment of Second-Year Pharmacy Students. Pharmacy, 10.","DOI":"10.3390\/pharmacy10060153"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.japh.2019.11.004","article-title":"Pharmacist attitudes toward pharmacy-based naloxone: A cross-sectional survey study","volume":"60","author":"Burstein","year":"2020","journal-title":"J. Am. Pharm. Assoc. JAPhA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12954-024-01018-6","article-title":"Community pharmacists\u2019 attitudes toward and practice of pharmacy-based harm reduction services in Pittsburgh, PA: A descriptive survey","volume":"21","author":"Klipp","year":"2024","journal-title":"Harm Reduct. J."},{"key":"ref_50","unstructured":"National Collaborating Centre for Methods and Tools (2026, September 08). CFIR-ERIC Implementation Strategy Matching Tool. Available online: https:\/\/www.nccmt.ca\/organizational-change\/results\/77."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/geront\/gnac157","article-title":"Identification of Implementation Strategies Using the CFIR-ERIC Matching Tool to Mitigate Barriers in a Primary Care Model for Older Veterans","volume":"63","author":"Shin","year":"2023","journal-title":"Gerontologist"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1007\/s11096-024-01773-3","article-title":"Correlates of stocking naloxone: A cross-sectional survey of community pharmacists","volume":"46","author":"Laing","year":"2024","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1748-5908-4-50","article-title":"Fostering implementation of health services research findings into practice: A consolidated framework for advancing implementation science","volume":"4","author":"Damschroder","year":"2009","journal-title":"Implement. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1037\/a0022284","article-title":"A guiding framework and approach for implementation research in substance use disorders treatment","volume":"25","author":"Damschroder","year":"2011","journal-title":"Psychol. Addctv. Behav."}],"container-title":["Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2226-4787\/14\/6\/137\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:11:36Z","timestamp":1789791096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2226-4787\/14\/6\/137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":54,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["pharmacy14060137"],"URL":"https:\/\/doi.org\/10.3390\/pharmacy14060137","relation":{},"ISSN":["2226-4787"],"issn-type":[{"value":"2226-4787","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]}}}